Science
Sniffing out cancer
Claire Guest, Co-founder of Medical Detection Dogs, explains how canines could have an important role in discovering disease.
Personalised pathology solutions
CliniSys’ Pathology Relationship Management (PRM) solution has been specifically designed to support healthcare professionals and the business of pathology.
Here to help: an evidence-based approach
Jocelyn Pryce, Head of Registration and Training at the IBMS, says keeping your portfolio pristine may not be the best way forward.
News
-
HOW WELL DO CANCER DRUGS HIT THEIR TARGETS?
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets in the body.
Cytopathology -
ATOMISING DISINFECTANTS FOR HOSPITALS
A team of engineers and physicians has developed a device that diffuses potent disinfectants for airborne delivery.
-
“CANCEROUS CELLS WORK TOGETHER TO INFILTRATE THE BRAIN”
Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain.
Cytopathology
Science
My lab: morecambe bay blood sciences
Biomedical Scientist Danny Gaskin gives a guided tour of his blood sciences lab at Furness General Hospital.
The big story: polynesian paradise lost
The islands of Polynesia are known to be some of the most beautiful in the world, but the influence of the colonising West has left its indelible mark, writes Stephen Mortlock.
Treating clostridium difficile infection
Emmanuel Nwankwo and Andrew Ward ask whether empirical antibiotic therapy can still be relied upon.
Latest Jobs
IBMS Twitter
Technology
FROM SPECIMEN TO SAFE DNA/RNA IN A SINGLE STEP
MWE recently launched its revolutionary new product Sigma MM Molecular Medium, which renders pathogenic material safe within seconds by killing any bacteria and viruses, while preserving intact DNA and RNA ready for molecular analysis.
Resources
Journal-based learning exercises
Each article’s contents should be read, researched and understood, and you should then come to a decision on each question.
The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date.
Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl
